HCW Biologics company info

What does HCW Biologics do?
HCW Biologics (NASDAQ:HCWB) is a clinical-stage company developing immunotherapies to combat chronic, low-grade inflammation, a hallmark of aging and many diseases. Their focus is on disrupting this inflammatory process to improve healthspan, essentially the length of healthy life. They're currently in the development phase of novel immunotherapeutic drugs and haven't launched any commercial products yet. HCW Biologics is a small-cap company with a market capitalization around $41 million.
HCW Biologics company media
Company Snapshot

Is HCW Biologics a public or private company?

key
Ownership
Public

How many people does HCW Biologics employ?

people
Employees
45

What sector is HCW Biologics in?

pie chart
Sector
Health Care

Where is the head office for HCW Biologics?

location pin
Head Office
Miramar, United States

What year was HCW Biologics founded?

founded flag
Year Founded
2018
What does HCW Biologics specialise in?
/Therapeutic Vaccines /Oncology Treatments /Autoimmune Therapies /Preclinical Development /Biopharmaceutical Research /Immunotherapy Solutions

What are the products and/or services of HCW Biologics?

Overview of HCW Biologics offerings
Immunotherapy Research & Development: HCW Biologics researches and develops novel immunotherapy drugs targeting chronic, low-grade inflammation.
Pre-Clinical and Clinical Trials: They conduct pre-clinical studies in labs and potentially clinical trials to test the safety and efficacy of their drug candidates.
Collaboration with Research Institutions: HCW Biologics might collaborate with other research institutions to advance their discoveries.
Data Analysis & Reporting: They analyze data from studies and trials, reporting findings to regulators and the scientific community.
Investor Relations & Communication: HCW Biologics communicates with investors regarding their progress and developments.
Intellectual Property Management: The company likely manages patents and other intellectual property related to their discoveries.

Who is in the executive team of HCW Biologics?

HCW Biologics leadership team
  • Dr. Hing C. Wong Ph.D.
    Dr. Hing C. Wong Ph.D.
    Founder, CEO, Director & Secretary
  • Ms. Rebecca  Byam CPA, M.B.A.
    Ms. Rebecca Byam CPA, M.B.A.
    Chief Financial Officer
  • Dr. Peter  Rhode Ph.D.
    Dr. Peter Rhode Ph.D.
    Chief Scientific Officer & VP of Clinical Operations
  • Ms. Nicole  Valdivieso Esq.
    Ms. Nicole Valdivieso Esq.
    Vice President of Legal Affairs
  • Ms. Raquel  Diaz M.S.
    Ms. Raquel Diaz M.S.
    Director of Human Resources
  • Mr. Lee D. Flowers
    Mr. Lee D. Flowers
    Senior Vice President of Business Development